JP2022533672A5 - - Google Patents
Info
- Publication number
- JP2022533672A5 JP2022533672A5 JP2021568854A JP2021568854A JP2022533672A5 JP 2022533672 A5 JP2022533672 A5 JP 2022533672A5 JP 2021568854 A JP2021568854 A JP 2021568854A JP 2021568854 A JP2021568854 A JP 2021568854A JP 2022533672 A5 JP2022533672 A5 JP 2022533672A5
- Authority
- JP
- Japan
- Prior art keywords
- microbial composition
- subject
- use according
- lactobacillus
- clostridium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962850773P | 2019-05-21 | 2019-05-21 | |
| US62/850,773 | 2019-05-21 | ||
| PCT/US2020/033870 WO2020236979A1 (en) | 2019-05-21 | 2020-05-20 | Methods and compositions for treating liver disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533672A JP2022533672A (ja) | 2022-07-25 |
| JP2022533672A5 true JP2022533672A5 (enExample) | 2023-05-25 |
Family
ID=73458208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568854A Pending JP2022533672A (ja) | 2019-05-21 | 2020-05-20 | 肝障害を処置するための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220211780A1 (enExample) |
| EP (1) | EP3973047A4 (enExample) |
| JP (1) | JP2022533672A (enExample) |
| KR (1) | KR20220011683A (enExample) |
| CN (1) | CN113993529A (enExample) |
| AU (1) | AU2020278703A1 (enExample) |
| CA (1) | CA3140096A1 (enExample) |
| SG (1) | SG11202112515RA (enExample) |
| WO (1) | WO2020236979A1 (enExample) |
| ZA (1) | ZA202110111B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2964480A1 (en) | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| JP2020532515A (ja) | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| EP3823651A4 (en) | 2018-07-19 | 2022-04-27 | Pendulum Therapeutics, Inc. | METHODS AND COMPOSITIONS FOR MICROBIAL TRANSPLANTATION |
| CA3140096A1 (en) * | 2019-05-21 | 2020-11-26 | Pendulum Therapeutics, Inc. | Methods and compositions for treating liver disorders |
| NL2030011B1 (en) * | 2021-12-03 | 2023-06-20 | Caelus Pharmaceuticals B V | Prevention or treatment of hepatic steatosis |
| EP4467148A4 (en) * | 2022-01-20 | 2025-04-23 | Korea Institute of Science and Technology | Composition for prevention, amelioration or treatment of non-alcoholic fatty liver disease, comprising extracellular vesicles derived from roseburia spp. or bifidobacterium spp |
| CN117599092B (zh) * | 2024-01-23 | 2024-04-26 | 南方医科大学南方医院 | 生孢梭菌在制备预防和/或治疗肝脏疾病的药物中的应用 |
| CN118526527A (zh) * | 2024-03-19 | 2024-08-23 | 华中科技大学同济医学院附属协和医院 | 益生菌混合液在制备预防或治疗apap诱导肝损伤药物中的应用 |
| KR102679094B1 (ko) * | 2024-04-24 | 2024-06-27 | 충남대학교 산학협력단 | 항비만 효능을 지닌 한국인 마이크로바이옴 유래 클로스트리디움 부티리쿰 균주 및 이의 용도 |
| CN119639633A (zh) * | 2025-02-18 | 2025-03-18 | 杭州师范大学附属医院(杭州市第二人民医院) | 一种治疗非酒精性脂肪肝的酵母菌益生菌复合物及其制备方法和应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2964480A1 (en) * | 2014-10-31 | 2016-05-06 | Whole Biome Inc. | Methods and compositions relating to microbial treatment and diagnosis of disorders |
| EP3842040B1 (en) * | 2016-01-11 | 2022-03-09 | Egetis Therapeutics AB | Methods and formulations for treatment of and/or protection against acute liver failure and other hepatotoxic conditions |
| CA3045026A1 (en) * | 2016-12-06 | 2018-06-14 | Whole Biome Inc. | Methods and compositions relating to isolated and purified microbes |
| JP2020532515A (ja) * | 2017-08-30 | 2020-11-12 | ペンデュラム セラピューティクス， インコーポレイテッド | マイクロバイオーム関連障害の処置のための方法および組成物 |
| KR102212606B1 (ko) * | 2017-09-28 | 2021-02-05 | 주식회사 고바이오랩 | 짧은 사슬 지방산 생성 장내 세균 군집의 변화를 이용한 알코올성 간 질환의 진단 및 치료용 조성물 |
| AU2019349678A1 (en) * | 2018-09-24 | 2021-04-15 | Pendulum Therapeutics, Inc. | Microbial compositions and methods of use |
| CA3140096A1 (en) * | 2019-05-21 | 2020-11-26 | Pendulum Therapeutics, Inc. | Methods and compositions for treating liver disorders |
-
2020
- 2020-05-20 CA CA3140096A patent/CA3140096A1/en active Pending
- 2020-05-20 EP EP20809882.2A patent/EP3973047A4/en not_active Withdrawn
- 2020-05-20 US US17/610,398 patent/US20220211780A1/en not_active Abandoned
- 2020-05-20 JP JP2021568854A patent/JP2022533672A/ja active Pending
- 2020-05-20 CN CN202080043100.6A patent/CN113993529A/zh active Pending
- 2020-05-20 KR KR1020217041642A patent/KR20220011683A/ko not_active Withdrawn
- 2020-05-20 SG SG11202112515RA patent/SG11202112515RA/en unknown
- 2020-05-20 AU AU2020278703A patent/AU2020278703A1/en not_active Abandoned
- 2020-05-20 WO PCT/US2020/033870 patent/WO2020236979A1/en not_active Ceased
-
2021
- 2021-12-07 ZA ZA2021/10111A patent/ZA202110111B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022533672A5 (enExample) | ||
| Derrien et al. | Fate, activity, and impact of ingested bacteria within the human gut microbiota | |
| Byakika et al. | A review of criteria and methods for evaluating the probiotic potential of microorganisms | |
| María Remes-Troche et al. | Lactobacillus acidophilus LB: A useful pharmabiotic for the treatment of digestive disorders | |
| Oliveira et al. | Use of lactulose as prebiotic and its influence on the growth, acidification profile and viable counts of different probiotics in fermented skim milk | |
| Hoesl et al. | The probiotic approach: an alternative treatment option in urology | |
| Venturi et al. | Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis | |
| Rosenfeldt et al. | Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhea | |
| Govender et al. | A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation | |
| Shah | Functional cultures and health benefits | |
| Saxelin et al. | Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese | |
| Alvaro et al. | Composition and metabolism of the intestinal microbiota in consumers and non-consumers of yogurt | |
| Walker et al. | Progress in the science of probiotics: from cellular microbiology and applied immunology to clinical nutrition | |
| US9125935B1 (en) | Probiotics and methods of obtaining same | |
| TWI594758B (zh) | 包含雙歧桿菌的組合物、其製備方法及其用途 | |
| US9962415B2 (en) | Lachnospiraceae in the gut microbiota and association with body weight | |
| CN111956676A (zh) | 一种包含人参提取物和益生菌的微生态制剂及其制备方法和应用 | |
| US20220211780A1 (en) | Methods And Compositions For Treating Liver Disorders | |
| Sanders | Summary of probiotic activities of Bifidobacterium lactis HN019 | |
| ITMI20131473A1 (it) | Metodo per valutare gli effetti di una composizione comprendente microrganismi sul microbiota intestinale | |
| Kolida et al. | Gastrointestinal microflora: probiotics | |
| Liu et al. | Efficacy of pasteurised yoghurt in improving chronic constipation: A randomised, double-blind, placebo-controlled trial | |
| CN104432001A (zh) | 可食用组合物及其用途 | |
| Matsumoto et al. | Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt | |
| Keller et al. | Bacillus coagulansas a probiotic |